Anti-cancer effect of Cyclin A/B RxL inhibitors is mediated in part by disruption of the ATR/Chk1 DNA repair pathway

CID-078 - Circle Pharma

https://www.abstractsonline.com/pp8/#!/20273/presentation/10046

Catherine E. Gleason1; Ranya Odeh1; Frances Hamkins-Indik1; Iolanda Vendrell2; Roman Fischer2; Benedikt Kessler2; Shilpa Singh3; Matthew Oser3; David J. Earp1; Marie Evangelista1; Pablo D. Garcia1

Mar 26, 2025